The authors present the case of a 51-year-old female with a syndrome of inappropriate secretion of antidiuretic hormone (SIADH) due to a malignant thymoma. Laboratory examinations of the patient showed hyponatremia, plasma hypoosmolarity in the presence of concentrated urine and normal urine excretion of sodium. CT revealed a mass lesion in the mediastinum. A biopsy of the mediastinal mass was performed and the diagnosis of thymoma with SIADH was established. This is a rare description of a malignant thymoma associated with SIADH.

Almong C, Horowitz M, Burke M: Steroid therapy in inappropriate secretion of antidiuretic hormone due to malignant thymoma. Respiration 1983;44:382–386.
Levin L, Sealy R, Barron J: Syndrome of inappropriate antidiuretic hormone secretion following dis-dichlorodiammineplatinum II in a patient with malignant thymoma. Cancer 1982;50:2279–2282.
Otsuka F, Hayashi Y, Ogura T, Hayakawa N, Ikeda S, Makino H, Ota Z: Syndrome of inappropriate antidiuretic hormone secretion following intra-thoracic cisplatin. Intern Med 1996;35:290–294.
Asada Y, Marutsuka K, Mitsukawa T, Kuribayashi T, Taniguchi S, Sumiyoshi A: Ganglioneuroblastoma of the thymus: An adult case with the syndrome of inappropriate secretion of antidiuretic hormone. Hum Pathol 1996;27:506–509.
Donadio AC, Dragnev KH, Schwartz GK: Thymoma associated with syndrome of inappropriate antidiuretic hormone secretion and myastenia gravis. South Med J 1998;91:278–279.
Imura H, Matsukura S, Yamamoto H, et al: Studies on ectopic ACTH-producing tumors. II. Clinical and biochemical features of 30 cases. Cancer 1975;35:1430–1437.
Winkler AW, Cranshaw OS: Chloride depletion conditions other than Addison’s disease. J Clin Invest 1938;17:1–6.
Schwartz WB, Bennett W, Curelop S, Bartter FC: A syndrome of renal loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 1957;23:529–542.
Leaf A, Bartter FC, Santos RF, Wrong O: Evidence in man that urinary electrolytes loss induced by pitressin is a function of water retention. J Clin Invest 1953;32:868–878.
Thorn NA, Transbol I: Hyponatremia and bronchogenic carcinoma associated with renal excretion of large amounts of antidiuretic material. Am J Med 1963;35:257–263.
Amatruda TT, Mulrow PJ, Gallanger JC, Sawyer WH: Carcinoma of the lung with inappropriate antidiuresis: Demonstration of antidiuretic-hormone-like activity in tumor extract. N Engl J Med 1963;269:544–549.
Moses AM, Miller M, Streeton DHP: Pathophysiologic and pharmacologic alterations in the release and action of ADH. Metabolism 1976;25:697–721.
De Troyer A, Demanet JC: Clinical, biological and pathogenic features of the syndrome of inappropriate secretion of antidiuretic hormone: A review of 26 cases with marked hyponatremia. Q J Med 1976;45:521–531.
Bartter FC, Schwartz WB: The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967;42:790–806.
Vorherr H: Para-endocrine tumor activity with emphasis on ectopic ADH secretion. Genetic, diagnostic, prognostic and therapeutic aspects. Oncology 1974;29:382–386.
Gschwantler M, Weiss W: Hyponatremic coma as the first symptom of a small cell bronchial carcinoma (in German). Dtsch Med Wochenschr 1994;119:261–264.
Coyle S, Penney MD, Masters PW, Walker BE: Early diagnosis of ectopic arginine vasopressin secretion. Clin Chem 1993;39:152–154.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.